Table 2.
Results from Analyses of Pain Growth Factors Predicting 12-Month Drinking Outcomes
COMBINE | β | B (SE) | R2 |
---|---|---|---|
12-month Percent Drinking Days (PDD) | 0.09 | ||
Baseline PDD | 0.30 | 0.52 (0.05)** | |
Pain interference intercept | 0.06 | 0.04 (0.02)* | |
Pain interference slope | 0.001 | 0.01 (0.13) | |
12-month Drinks per Drinking Day (DDD) | 0.07 | ||
Baseline DDD | 0.22 | 0.17 (0.02)** | |
Pain interference intercept | 0.11 | 0.01 (0.003)** | |
Pain interference slope | 0.01 | 0.01 (0.02) | |
12-month Percent Heavy Drinking Days (PHDD) | 0.06 | ||
Baseline PHDD | 0.22 | 0.33 (0.05)** | |
Pain interference intercept | 0.08 | 0.05 (0.02)* | |
Pain interference slope | −0.001 | −0.006 (0.13) | |
12-month Maximum Drinks per Day (MXD) | 0.05 | ||
Baseline MXD | 0.18 | 0.10 (0.02)** | |
Pain interference intercept | 0.12 | 0.02 (0.004)** | |
Pain interference slope | 0.01 | 0.01 (0.03) | |
UKATT | β | B (SE) | R2 |
12-month Percent Drinking Days (PDD) | 0.10 | ||
Baseline PDD | 0.25 | 0.40 (0.07)** | |
Pain interference and intensity intercept | 0.08 | 0.04 (0.02)* | |
Pain interference and intensity slope | 0.15 | 0.35 (0.50) | |
12-month Drinks per Drinking Day (DDD) | 0.16 | ||
Baseline DDD | 0.38 | 0.34 (0.01)** | |
Pain interference and intensity intercept | 0.09 | 0.02 (0.007)* | |
Pain interference and intensity slope | 0.11 | 0.09 (0.14) | |
12-month Percent Heavy Drinking Days (PHDD) | 0.09 | ||
Baseline PHDD | 0.25 | 0.38 (0.06)** | |
Pain interference and intensity intercept | 0.09 | 0.05 (0.02)* | |
Pain interference and intensity slope | 0.13 | 0.30 (0.44) | |
12-month Maximum Drinks per Day (MXD) | 0.15 | ||
Baseline MXD | 0.36 | 0.33 (0.04)** | |
Pain interference and intensity intercept | 0.10 | 0.02 (0.01)* | |
Pain interference and intensity slope | 0.11 | 0.13 (0.24) |
p < 0.05;
p < 0.01;
β = standardized regression coefficient; B = unstandardized regression coefficient (SE = Standard Error)